Related Experiment Video
Updated: Mar 31, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Beyond hemoglobin thresholds: A physiology-guided framework for red blood cell transfusion in non-bleeding critically
Thanh Luan Nguyen1,2, Quang Dai Le3, Phan Ngoc An Huynh1
1Faculty of Medicine, Nam Can Tho University, Can Tho City, Vietnam.
None:
Red blood cell transfusion in non-bleeding critically ill patients is traditionally guided by fixed hemoglobin thresholds. Although restrictive strategies are widely recommended based on population-level randomized trials, hemoglobin concentration alone inadequately reflects the complex physiology of oxygen delivery, tissue perfusion, and cellular oxygen utilization in critical illness. Increasing evidence suggests frequent dissociation between hemoglobin increments and meaningful improvements in tissue oxygenation, particularly in the presence of microcirculatory dysfunction, impaired oxygen extraction, or mitochondrial failure. Moreover, recent trials in patients with limited cardiovascular reserve or acute myocardial ischemia challenge the universal safety of restrictive transfusion thresholds, emphasizing interindividual variability in oxygen supply-demand balance. In this mini-review and expert perspective, we synthesize physiological principles, landmark transfusion trials, and emerging monitoring modalities to propose a practical physiology-guided framework for red blood cell transfusion in non-bleeding critically ill patients. We review global, regional, and cellular markers of oxygen balance, including central venous oxygen saturation, oxygen extraction ratio, arterial-venous oxygen content difference, near-infrared spectroscopy-derived tissue oxygenation, microcirculatory flow indices, and mitochondrial oxygen tension, highlighting complementary roles and inherent limitations. We propose a pragmatic bedside approach in which transfusion is considered only after optimization of non-transfusion determinants of oxygen delivery and guided by integrated physiologic evidence of oxygen debt. This paradigm reframes transfusion as targeted therapy rather than numerical correction of anemia. Future research should combine outcome-driven randomized trials with large-scale data-driven and machine learning approaches to validate physiologic transfusion triggers and identify transfusion-responsive phenotypes in critical illness.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
10:32Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Rh Blood Group
Erythropoiesis
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...